Dr. Klopper is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6000 Shoreline Court
Suite 300
South San Francisco, CA 94080
Education & Training
- University of ColoradoFellowship, Endocrinology, Diabetes, and Metabolism, 2002 - 2006
- University of ColoradoResidency, Internal Medicine, 1999 - 2002
- Emory University School of MedicineClass of 1999
Certifications & Licensure
- CO State Medical License 2002 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
Publications & Presentations
PubMed
- 26 citationsThyroid Cancer Resistance to Vitamin D Receptor Activation Is Associated with 24-Hydroxylase Levels But Not the ff FokI PolymorphismVibha Sharma, Deborah L. Fretwell, Zachary Crees, Anna Kerege, Joshua P. Klopper
Thyroid. 2010-10-01 - 81 citationsRetinoic acid and retinoid X receptors are differentially expressed in thyroid cancer and thyroid carcinoma cell lines and predict response to treatment with retinoids.Bryan R. Haugen, Lori Lee Larson, Umarani Pugazhenthi, William R. Hays, Joshua P. Klopper
The Journal of Clinical Endocrinology and Metabolism. 2004-01-01 - 124 citationsTumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer.Jena D. French, Zachary Weber, Deborah L. Fretwell, Sherif Said, Joshua P. Klopper
The Journal of Clinical Endocrinology and Metabolism. 2010-05-01
Press Mentions
- Veracyte Announces New Data Suggesting Afirma Testing Can Help Personalize Care for Patients with Thyroid NodulesFebruary 1st, 2023
- Veracyte Further Strengthens Medical Team with Appointment of Joshua Klopper, M.D., as Medical Director of EndocrinologySeptember 1st, 2021
- Veracyte Announces Novel Afirma-Based Findings That Advance Molecular Understanding of Thyroid Cancer to Be Presented at the 2023 ATA Annual MeetingSeptember 23rd, 2023
- Join now to see all
Professional Memberships
- Member
- Member
External Links
- KP profilehttps://healthy.kaiserpermanente.org/colorado-denver-boulder-mountain-northern/clinicians/joshua-klopper-7081910
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: